TheraRadar
← Back
Data updated: Mar 29, 2026

RANBAXY LABS LTD

Infectious DiseaseGastroenterologyDermatology
Generics

RANBAXY LABS LTD is a generic drug manufacturer focused on Infectious Disease, Gastroenterology, Dermatology.

1964
Since
41
Drugs
-
Trials
529
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

GABAPENTIN 2026-02-24
Labeling
DOXYCYCLINE HYCLATE 2026-02-19
GABAPENTIN 2026-02-18
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-12
Labeling
PRAVASTATIN SODIUM 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 36%
4 drugs
Gastroenterology 18%
2 drugs
Dermatology 18%
2 drugs
Immunology 18%
2 drugs
Respiratory 9%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Dermatology, Immunology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology, Respiratory
PHARMACIA AND UPJOHN big-pharma
Dermatology, Infectious Disease, Respiratory, Immunology
Gilead Sciences biotech
Infectious Disease, Immunology, Gastroenterology, Respiratory
MALLINCKRODT specialty
Gastroenterology, Dermatology, Immunology, Respiratory